KMLE
»çÀÌÆ® ¼Ò°³
°Ë»ö
°Ë»ö¾î Áö¿ì±â
´Ý±â
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
°í±Þ °Ë»ö ¼³Á¤
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú :
14
ÆäÀÌÁö:
20
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
Æ®¸®Å¸µòÁ¤
Trimetazidine HCl 20 mg
È޿½º
Àü¹®|»èÁ¦
0¿ø/1 °³
Æ®¸®¼¼¸°ÁÖ10mg
Nitroglycerin 10 mg
´ëÇÑ´ºÆÊ
Àü¹®|»èÁ¦
0¿ø/10 °³
Æ®¶ó¸°Á¤50mg
Sertraline HCl 50 mg
¸íÀÎÁ¦¾à
Àü¹®|±Þ¿©
811¿ø/1 °³
Æ®·¯Á¨Á¤
Bromelain 45 mg, Papain 60 mg, Trypsin 24 mg
´ºÁ¨ÆÊ
ÀϹÝ|»èÁ¦
0¿ø/1 °³
Æ®¸®Äݸ°¿¬Áúĸ½¶
Bromelain 50 mg, Dehydrocholic Acid 25 mg, Pancreatin 150 mg, Trimebut...
À¯¿µÁ¦¾à
Àü¹®|»èÁ¦
0¿ø/1 °³
Æ®¸®¸ÞÅ»Á¤
Sodium Bicarbonate 50 mg, Trimebutine Maleate 50 mg, Magnesium Alumino...
¹Ì·¡Á¦¾à
ÀϹÝ|»èÁ¦(ºñ±Þ¿©Àüȯ)
0¿ø/1 °³
Æ®³ªÀÎÅ©¸²
Prednisolone Valeroacetate 3 mg
º¸¶÷Á¦¾à
ÀϹÝ|»èÁ¦
0¿ø/1 °³
Æ®·ç¾Æ¹ÎÁÖ
L-Isoleucine 6.38 g/L, L-Leucine 11.13 g/L, Lysine HCl 8.75 g/L, L-Met...
º¸·ÉÁ¦¾à
Àü¹®|»èÁ¦
0¿ø/250 °³
Æ®¸®µ¹¼Ö·çºíÁ¤
Tramadol HCl 50 mg
À¯ÇѾçÇà
Àü¹®|±Þ¿©
170¿ø/1 °³
Æ®¶ó¹ÙźÁ¡¾È¾×0.004%
travoprost 0.04 mg/mL
Çѱ¹¾ËÄÜ
Àü¹®|±Þ¿©
9097¿ø/1 °³
Æ®·ÎÆæÁÖ
Diclofenac Sodium 75
Çѱ¹ÇÁ¶óÀÓÁ¦¾à
Àü¹®|»èÁ¦
0¿ø/2 °³
Æ®¸®¸Þ°¡°ÇÁ¶½Ã·´
Trimebutine Maleate 4.8 mg/mL
µå¸²ÆÄ¸¶
Àü¹®|±Þ¿©
16¿ø/1 °³
Æ®¶óº£½ÅÁÖ»ç100mg
Labetalol HCl 100
ºñƼ¿ÀÁ¦¾à
Àü¹®|»èÁ¦
0¿ø/20 °³
Æ®·»Å¹½ÇÁÖ»ç100mg
Pentoxifylline 100
ºñƼ¿ÀÁ¦¾à
Àü¹®|»èÁ¦
0¿ø/5 °³
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
hyponatremia
Àú³ªÆ®·ýÇ÷Áõ
hypoprothrombinemia
ÀúÇÁ·ÎÆ®·ÒºóÇ÷Áõ
hyposomatotropism
Àú¼Ò¸¶Å䯮·ÎÇÉÁõ
hypsarrhythmia
Á¡µÎ°æ·ÃÀdzúÆÄ, Èü½º¾Æ¸®Æ®¹Ì¾Æ
heat stress
¿½ºÆ®·¹½º
hematocrit
ÀûÇ÷±¸¿ëÀû·ü, Ç츶ÅäÅ©¸®Æ®
hemerythrin
Ç÷Àû¼Ò, Çì¸Þ¸®Æ®¸°
hereditary methemoglobinemic cyanosis
À¯Àü¸ÞÆ®Çì¸ð±Û·ÎºóÇ÷û»öÁõ
histothrombin
Á¶Á÷Æ®·Òºó
holy fire
¿¡¸£°íÆ®Áßµ¶Áõ, ¸Æ°¢Áßµ¶Áõ
homatropine
È£¸¶Æ®·ÎÇÉ
horizontal mattress suture
¼öÆò¸ÅÆ®¸®½ººÀÇÕ
human chorionic somatomammotropin
»ç¶÷À¶¸ð¸öÁ¥»ùÀÚ±ØÈ£¸£¸ó, »ç¶÷À¶¸ð¼Ò¸¶Å丶¸ðÆ®·ÎÇÉ
hard contact lens
ÇϵåÄÜÅÃÆ®·»Áî, °æ¼ºÄÜÅÃÆ®·»Áî
hydrocortisone acetate
È÷µå·ÎÄÚ¸£Æ¼¼Õ¾Æ¼¼Å×ÀÌÆ®
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
olfact
¿ÃÆÅÆ®, Èİ¢´ÜÀ§
osteocement
»À½Ã¸àÆ®
oxygen tent
»ê¼ÒÅÙÆ®
pagetoid
ÆÄÁ¦Æ®º´¸ð¾ç
paint
µµÆ÷Á¦, ÆäÀÎÆ®
paratrachoma
ÆÄ¶óÆ®¶óÄÚ¸¶
pectinate
ÆåÆ®»ê¿°, ºø¸ð¾ç-
pentagastrin
ÆæÅ¸°¡½ºÆ®¸°
Peptostreptococcus
ÆéÅ佺Ʈ·¾ÅäÄÚÄí½º, ÆéÅä»ç½½¾Ë±Õ
pest
Æä½ºÆ®, Èæ»çº´
pestis
(¢¡pest) Æä½ºÆ®, Èæ»çº´
pestis bubonica
(¢¡bubonic plague) °¡·¡ÅêÆä½ºÆ®, °¡·¡ÅêÈæ»çº´, ¸²ÇÁÀýÆä½ºÆ®
plague
Æä½ºÆ®, Èæ»çº´
prothrombin
ÇÁ·ÎÆ®·Òºó
prothrombinase
ÇÁ·ÎÆ®·ÒºóºÐÇØÈ¿¼Ò
ÀÌÀü
´ÙÀ½
Sponsored Links
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
Titmus test
ƼƮ¹«½º°Ë»ç
Todd-Hewitt broth
Åäµå-ÈÞÆ® ¾×ü¹èÁö
Treponema carateum
ÇÉŸƮ·¹Æ÷³×¸¶
Treponema pallidum
¸Åµ¶Æ®·¹Æ÷³×¸¶
Treponema pallidum
¸Åµ¶Æ®·¹Æ÷³×¸¶, Æ®·¹Æ÷³×¸¶¸Åµ¶±Õ.
Treponema pallidum
¸Åµ¶Æ®·¹Æ÷³×¸¶, Æ®·¹Æ÷³×¸¶¸Åµ¶±Õ.
Treponema pertenue
ÇÁ¶÷º£Áö¾Æ Æ®·¹Æ÷³×¸¶
Treponema pertenue
ÇÁ¶÷º£Áö¾Æ Æ®·¹Æ÷ ³×¸¶.
Treponema pertenue
ÇÁ¶÷º£Áö¾Æ Æ®·¹Æ÷ ³×¸¶.
Trichomonas vaginalis
ÁúÆ®¸®Äڸ𳪽º
Trypanosoma cruzi
Å©·çÁî Æ®¸®ÆÄ³ë¼Ò¸¶
Trypanozoma gambiense
°¨ºñ¾Æ Æ®¸®ÆÄ³ë¼Ò¸¶
Trypanozoma rangeli
¶õ°Ö Æ®¸®ÆÄ³ë¼Ò¸¶
Trypanozoma rhodesiense
·Îµ¥½Ã¾Æ Æ®¸®ÆÄ³ë¼Ò¸¶
VDRL test= venereal disease research laboratory test
¼ºº´¿¬±¸¼Ò½ÄÅ×½ºÆ®.
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
cothromboplastin
ÄÚÆ®·Òº¸ÇÃ¶ó½ºÆ¾.
cothromboplastin factor VII
ÄÚÆ®·Òº¸ÇÃ¶ó½ºÆ¾.
creutzfeldt-jakob disease
Å©·ÎÀÌÃ÷ÆçÆ®¾ßÄߺ´(¡Ü»)
crotchet
Å©·ÎüƮºÐ¸¸±¸.
crown cementum
Ä¡°ü½Ã¸àÆ®Áú(¡òõ).
crusta petrosa
Ä¡¾Æ ½Ã¸àÆ®.
cyanide-nitroprusside test
½Ã¾ÈÈ-³ªÀÌÆ®·ÎǪ¸£»çÀÌµå °Ë»ç
cyanide-nitroprusside test
½Ã¾Èȹ°-´ÏÆ®·ÎǪ¸£»çÀ̵å½ÃÇè
cyanmethemoglobin
½Ã¾È¸ÞÆ®Çì¸ð±Û·Îºó.
cyanmethemoglobin=hemiglobincyanide
½Ã¾È¸ÞÆ®Çì¸ð±Û·Îºó
cyclamates
»çÀÌŬ¶ó¸ÞÀÌÆ®
cyclic AMP ; cyclic adenosine mono pho sph ate
°í¸®¸ð¾ç AMP.¾à¸®È¯ ½Ä±¸¾Æ³ë½Å¸ð³ëÆ÷½ºÆäÀÌÆ®, »çÀÌŬ¸¯AMP, cAMP cyclic aclenosine 3 , 5 monophate
cyclotron
»çÀÌŬ·ÎÆ®·Ð
cylinder cast
¿øÅëÇü ¼®°í(ê÷Õû¡à´ÍÇ), ¿øÁÖÇü ¼®°í(êñ»û¡à´ÍÇ), ½ÅÀüÀ§ ¼®°í ºØ´ë(ãßî÷êÈà´ÍÒÝÞÓá), ½Ç¸°´õ ij½ºÆ®, ¿øÅë»ó ¼®°í ºØ´ë.
cymbiform
¹è¸ð¾ç, ÁÖ»ó, ÁÖÇü, º¸¿ìÆ®Çü (¡û¡).
ÀÌÀü
´ÙÀ½
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
oxytetracycline
¿Á½ÃÅׯ®¶ó»çÀÌŬ¸°
palmitic acid
ÆÈ¹ÌÆ®»ê(ß«)
pectate lyase
ÆåÆ®»ê ¶óÀÌ¿¡À̽º
pectic acid
ÆåÆ®»ê(ß«)
pellet
"Æç·¹, Æç·¹Æ®"
peptidyl transferase
ÆéƼµô Æ®·£½ºÆÛ·¹À̽º
peptidyl transferase center
ÆéƼµô Æ®·£½ºÆÛ·¹À̽º Áß½É(ñéãý)
percentage average deviation
"ÆÛ¼¾Æ®(¹éºÐÀ²,ÛÝÝÂ×Ë) Æò±ÕÆíÂ÷(øÁгø¶ó¬)"
percentage error
"ÆÛ¼¾Æ®(¹éºÐÀ²,ÛÝÝÂ×Ë) ¿ÀÂ÷(è¦ó¬)"
percentage law
"ÆÛ¼¾Æ®(¹éºÐÀ²,ÛÝÝÂ×Ë) ¹ýÄ¢(ÛööÎ)"
percent ionization
ÀÌ¿ÂÈ(ûù) ÆÛ¼¾Æ®
percent solution
ÆÛ¼¾Æ® ¿ë¾×(éÁäû)
percent transmittance
ÆÛ¼¾Æ® Åõ°úµµ(÷âÎ¦Óø)
perhydrocyclopentanophenanthrene
ÆÛÇÏÀ̵å·Î»çÀÌŬ·ÎÆæÅ¸³ëÆä³Æ®·»
permanent dipole moment
¿µ±¸½Ö±ØÀÚ(çµÎùäªÐ¿í) ¸ð¸àÆ®
ÀÌÀü
´ÙÀ½
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú :
5
ÆäÀÌÁö:
20
ÄÚµå
¿µ¹®
ÇѱÛ
V52.3
Unspecified occupant of pick-up truck or van injured in nontraffic accident
ºñ±³Åë»ç°í¿¡¼ ´ÙÄ£ »ó¼¼ºÒ¸íÀÇ ÇȾ÷Æ®·° ¶Ç´Â ¹êÀÇ Å¾½ÂÀÚ
V52.9
Unspecified occupant of pick-up truck or van injured in traffic accident
±³Åë»ç°í¿¡¼ ´ÙÄ£ »ó¼¼ºÒ¸íÀÇ ÇȾ÷Æ®·° ¶Ç´Â ¹êÀÇ Å¾½ÂÀÚ
V53
Occupant of pick-up truck or van injured in collision with car, pick-up truck or van
½Â¿ëÂ÷, ÇȾ÷Æ®·° ¶Ç´Â ¹ê°ú Ãæµ¹·Î ´ÙÄ£ ÇȾ÷Æ®·° ¶Ç´Â ¹ê ž½ÂÀÚ
V53.3
Unspecified occupant of pick-up truck or van injured in nontraffic accident
ºñ±³Åë»ç°í¿¡¼ ´ÙÄ£ »ó¼¼ºÒ¸íÀÇ ÇȾ÷Æ®·° ¶Ç´Â ¹êÀÇ Å¾½ÂÀÚ
V53.9
Unspecified occupant of pick-up truck or van injured in traffic accident
±³Åë»ç°í¿¡¼ ´ÙÄ£ »ó¼¼ºÒ¸íÀÇ ÇȾ÷Æ®·° ¶Ç´Â ¹êÀÇ Å¾½ÂÀÚ
ÀÌÀü
´ÙÀ½
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
¼³¸í
lyotrope
¸®¿ÀÆ®·ÎÇÁ °è¿
malachite green
¸»¶óÄ«ÀÌÆ® ±×¸°, ¸È·¯Ä«ÀÌÆ® ÃÊ·Ï
malachite green test
¸È·¯Ä«ÀÌÆ® ±×¸®ÀÎ ½ÃÇè
maltodextrin
¸Æ¾Æ µ¦½ºÆ®¸°
ºÐÇØÇØ¼ ¸»ÅäÁî·Î ÀüȯµÇ´Â µ¦½ºÆ®¸°.
maltotriose
¸»Å䯮¶óÀÌ¿À½º
ÀüºÐ ¶Ç´Â ±Û¶óÀÌÄÚÁ¨¿¡ ¾Æ¹Ð·¹À̽º°¡ ÀÛ¿ëÇØ¼ »ý¼ºµÈ 3ºÐÀÚÀÇ ±Û·çÄÚ½º·Î ÀÌ·ç¾îÁø ´ç.
mammotrophs
¸¾¸ðÆ®·ÎÇÁ
manninotriose
¸¸´Ï³ëÆ®¶óÀÌ¿À½º
mat gold
¸ÅÆ® ±Ý
ÀüÂøÀ¸·Î ó¸®µÈ ºñÀÀÁý¼º ¼ø±ÝÀÇ ÇüÅÂ. ¾ÆÁÖ ¾ã°í ÀÛÀº ½Î·¡±â °°Àº °áÁ¤ ÇüÅÂÀÇ ¼ø±ÝÀ¸·Î Ä¡°æ 1/3ºÎ ¼öº¹¿¡ ÀÀÁý¼º ±Ý¹Ú°ú ÇÔ²² »ç¿ëÇÑ´Ù.
matrass
¸¶Æ®¶ó½º
¸ñÀÌ ±ä À¯¸® ¿ë±â·Î¼, °ÇÁ¶ÇÑ ¹°ÁúÀÇ ÈÇÐÀû 󸮿¡ »ç¿ëµÈ´Ù.
matrix adaptor
¸ÅÆ®¸¯½º ÀûÇÕ±â
matrix crown
¸ÞÆ®¸¯½º ÁÖÁ¶°ü
±Ý¼Ó°üÀÇ ÀÏÁ¾À¸·Î¼ Áö´ëÄ¡ À§¿¡ 34¹øÀÇ ¼ø±Ý ÆÇÀ» ¾ÐÁ¢ÇÏ¿© ¸ÞÆ®¸¯½º¸¦ Á¦ÀÛÇϰí, ÀÌ À§¿¡ ¼ºÇüÀ» ÇÏ¿© ÁÖÁ¶ ÈÄ ¸ÞÆ®¸¯½º¿Í ÁÖÁ¶ºÎ¸¦ ÇÕÁ¢ÇÏ¿© ¿Ï¼ºÇÑ´Ù. ±Ý¼ÓÀÇ ÁÖÁ¶ ¼öÃàÀ» ¹æÁöÇϹǷΠÀûÇÕÀÌ ÁÁ´Ù.
matrix retainer
¸ÅÆ®¸¯½º À¯Áö ÀåÄ¡, ¸ÅÆ®¸¯½º À¯Áö±â, ¸ÅÆ®¸¯½º ÁöÁö´ë
matrixadaptor
¸ÅÆ®¸¯½º ÀûÇÕ±â
mattress
¸ÅÆ®¸®½º
ħ´ë¿¡ ±î´Â °Í.
Mauthner's sheath
¸¶¿ìÆ®³Ê ÃÊ
ÀÌÀü
´ÙÀ½
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú:
10
ÆäÀÌÁö:
20
Æ®¸®±×¸°Ä¸½¶
A31804371
ÆÇ¸Å»ç: ¸í¹®Á¦¾à
¼ººÐ/ÇÔ·®: Triflusal
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Æ®·ç»ìĸ½¶
A20602751
ÆÇ¸Å»ç: ¹Ì·¡Á¦¾à
¼ººÐ/ÇÔ·®: Triflusal
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Æ®·¹Àο¬Áúĸ½¶
A08852931
ÆÇ¸Å»ç: º¸¶÷Á¦¾à
¼ººÐ/ÇÔ·®: Isotretinoin
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Æ®¸®¼ÕŰƮÁÖ»ç
A80300101
ÆÇ¸Å»ç: À¯ÄÉÀÌÄÉ¹ÌÆÊ
¼ººÐ/ÇÔ·®: Ceftriaxone Sodium, Sodium Chloride
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Æ®¶óºóÁÖ100mg
A12253681
ÆÇ¸Å»ç: Çѱ¹À¯´Ï¿ÂÁ¦¾à
¼ººÐ/ÇÔ·®: Cytarabine
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Æ®¸®Æ¾¾×
A62753711
ÆÇ¸Å»ç: Çѱ¹ÇÁ¶óÀÓÁ¦¾à
¼ººÐ/ÇÔ·®: Ranitidine HCl
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
Æ®¸®ÆÄÁ¦Á¤
A12253881
ÆÇ¸Å»ç: Çѱ¹À¯´Ï¿ÂÁ¦¾à
¼ººÐ/ÇÔ·®: Bromelain, Papain, Trypsin
±¸ºÐ/º¸Çè±Þ¿©: ÀϹÝÀǾàǰ | ºñ±Þ¿©
Æ®¸®³ªÁ¦Á¤
A00750611
ÆÇ¸Å»ç: µ¿±¹Á¦¾à
¼ººÐ/ÇÔ·®: Streptodornase, Streptokinase
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | »èÁ¦
Æ®¸®¾Æ¹Ì´Ð¾¾¾Ø¿¡À̽÷´
E01631041
ÆÇ¸Å»ç: Çѱ¹³ë¹ÙƼ½º
¼ººÐ/ÇÔ·®: Chlorpheniramine Maleate, Pseudoephedrine HCl
±¸ºÐ/º¸Çè±Þ¿©: ÀϹÝÀǾàǰ | ±Þ¿©
Æ®¸®Å×À̽ºÇ÷¯½ºÁ¤5/25mg
A07404711
ÆÇ¸Å»ç: Çѵ¶¾àǰ
¼ººÐ/ÇÔ·®: Hydrochlorothiazide, Ramipril
±¸ºÐ/º¸Çè±Þ¿©: Àü¹®ÀǾàǰ | ±Þ¿©
ÀÌÀü
´ÙÀ½
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
Cosa Nostra
ÄÚÀڳ뽺Ʈ¶ó(¹Ì±¹ ¸¶ÇǾÆÀÇ ºñ¹ÐÁ¶Á÷)
Cote d'Azur
ÄÚÆ®´ÙÁ㸣(ÇÁ¶û½º ³²µ¿ºÎ,ÁöÁßÇØ ¿¬¾ÈÀÇ º¸¾ç °ü±¤Áö)
Cottrell precipitator
ÄÚÆ®·¼ ÁýÁø±â(Àü±â ÁýÁø±âÀÇ ÀÏÁ¾)
Coventry
ÄÚ¹øÆ®¸®(¿µ±¹ WarwickshireÁö¹æÀÇ µµ½Ã)
Cowes
Ä«¿ì½º(¿µ±¹ Wight¼¶ÀÇ Ç×±¸,ÇØ¼ö¿åÀå.¿äÆ®°æÁÖÀå)
Creutzfeldt-Jakob disease
Å©·ÎÀÌÃ÷ÆçÆ®¾ßÄߺ´
Czerny
ü¸£´Ï(¿À½ºÆ®¸®¾ÆÀÇ ÇǾƴϽºÆ®)
Dadaist
Ç㹫ÁÖÀÇÀû ¿¹¼ú°¡;´Ù´ÙÀ̽ºÆ®
Dalai Lama
´Þ¶óÀ̶ó¸¶(Ƽº£Æ®ÀÇ È¯ºÒ)
Danang
´Ù³¶(º£Æ®³² Áßµ¿ºÎÀÇ Ç×±¸ µµ½Ã)
Dandie Dinmont
´íµðµò¸óÆ® Å׸®¾î(µ¿Ã¼°¡ ±æ°í ´Ù¸®°¡ ¬Àº Å׸®¾î°³ÀÇ ÀÏÁ¾)
Dartmoor
À×±Û·£µå ³²¼ºÎÀÇ ¹ÙÀ§°¡ ¸¹Àº °í¿ø;´ÙÆ®Äí¾î Çü¹«¼Ò
Dartmouth
´ÙÆ®¸Ó½º(¿µ±¹ DevonÁÖÀÇ Ç×±¸);(±×°÷ÀÇ)´ÙÆ®¸Ó½º ÇØ±º »ç°üÇб³
Datapost
(¿µ)µ¥ÀÌÅÍÆ÷½ºÆ®(ÀÍÀÏ ¹è´Þ ¼ÒÆ÷ ¿ìÆí)
Delta blues
µ¨Å¸ ºí·ç½º(ÄÁÆ®¸® ¹ÂÁ÷)
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
Á¦Ç°¸í
¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
ÀÌÀü
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
ÀÌÀü
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÇÑÀÚ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑ»ýÈÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
ÀÌÀü
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
ÀÌÀü
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
ÄÚµå
¿µ¹®
ÇѱÛ
ÀÌÀü
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
¼³¸í
ÀÌÀü
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú:
0
ÆäÀÌÁö:
20
ÀÌÀü
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
20
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½